Loading…
This event has ended. Visit the official site or create your own event on Sched.
Credit Type: CME [clear filter]
arrow_back View All Dates
Monday, June 27
 

8:30am EDT

#106: Fostering a Partnership to Advance Innovation: Niche Service Leads to Breakthrough in Patient Recruitment and Retention Challenges 112AB #117: IDMP: A Compliance Project or a New Way of Conducting Business? 109AB #101: Opportunities for Improving Informed Consent of Clinical Research Volunteers 113C #102: Digital Health Debate 113A #103: Decision Tools to Drive Efficient Recruitment and Retention: Making Recruitment a Science 113B #104: Impact of Biologics, Vaccines, Oncology, and Breakthrough Therapy Designation on Traditional Global Drug Development Strategy 105AB #105: Maximize the Value of Your Product by Beginning with the End in Mind 107AB #107: Fatal Drug Trials in Phase 1: Understanding Risk, Subject Safety, Timelines, and Cost 202AB #113: Clinical Developments in Immuno-Oncology, Part 1 of 2: Science, Current Methodologies, and Achievements 108B #108: Drug/In Vitro Diagnostic Device Advertising and Promotion: Unapproved Combination Product or Awareness? 203AB #109: EHR in Clinical Research: Heralding a New Era 201C #110: Updates and Pending Issues in the US Biosimilar Environment 201B #111: Global Regulatory Harmonization in Asia: Is a New Trend Occurring? 204B #112: The Upcoming European Clinical Trials Regulation 204C #114: Bringing the Trial to the Patient: Making the Patient Voice Central from Trial Design Onward 204A #115: Clinically Relevant Specifications: Translating Voice of the Patient Into Quality Attributes of the Product 111AB #116: Has the EU Good Pharmacovigilance Practices Delivered on Its Intended Promise and Commitment? 103C #118: The Interpretation of PRO Scores and Responder Analyses in the Presence of Missing Data 201A #119: Narrative Medicine: Innovative Techniques for Including the Voice of the Patient in Clinical Trials 102AB #121: Rare Disease Clinical Trials: Coping with Unique Challenges 103A

10:45am EDT

#123: Global Clinical Trials: Innovative Approaches to Clinical Trials in Japan, India, and Latin America 113B #124: Risk-Based Monitoring in Clinical Trials 113C #125: Patient Recruitment in Rare Diseases: Ideas and Framework for Out-of-the-Box Exploration 113A #126: Hope Is Not a Strategy: Quantifying Knowledge for Better Decision Making in Clinical Development 102AB #127: Innovative Partnerships: gOVERN - A Research and Early Development’s Outsourcing Vision to Enable Resourcing INovation 112AB #128: Alliance Management Forum 111AB #129: Delivering Value Through Medical Information Metrics 203AB #130: Take Two Aspirin and Text Me in the Morning: Technology Suited for 20,000 Virtual Patients on the PCORI Aspirin Trial 201C #132: Electronic Implementation of New PRO Measures to Assess Treatment Benefit in Irritable Bowel Syndrome Trials: Lessons Learned 204C #131: IDMP Update 204B #133: Take Advantage of Global Expedited Pathways: Breakthrough, Sakigake, PRIME! 201B #135: Clinical Developments in Immuno-Oncology, Part 2 of 2: Clinical Implementation of Biomarkers 108B #134: How Can We Utilize Mobile Health for Better Quality of Life and Medical Economy? 103A #136: Clinical Data Disclosure and Transparency: ClinicalTrials.gov Final Rule, EU Requirements, and Other Key Updates 202AB #137: Using Technology to Make Trials Accessible to More Clinical Trial Participants 204A #138: Risk Communication and Management: The Art of Communicating Risk - Challenges and Best Practices 109AB #139: Measuring the Impact and Influence of Patient Input on Regulatory and Health Technology Assessment Decision Making: What Are the Key Considerations? 105AB #140: Understanding, Developing, and Implementing an Anticipated Events Review Process: Adoption of the FDA IND Rule on Safety Reporting Requirements 108A #141: Transforming Health Care Data for Clinical Research: Strategy and Experiences from the PCORnet Common Data Model 201A #143: Priority Review Vouchers: Past Experiences, Legislative Reform, and Tips for Sponsors 103C
 

Filter sessions
Apply filters to sessions.
Filtered by Credit Type (CME) - 
  • Preconference Tutorial
  • Trk 01: Clinical Operations
  • Trk 02: Proj-Port Mgt-Strat Planning
  • Trk 02: Proj/Port Mgt/Strat Planning
  • Trk 03: Innov Part Model-Outsourcing
  • Trk 03: Innov Part Model/Outsourcing
  • Trk 04: Preclin Transl-Early Clin Dev
  • Trk 05: Reg of Prod Adv-Mkting
  • Trk 05: Reg of Prod Adv/Mkting
  • Trk 06: Med Comm-Wrtg-MSL
  • Trk 06: Med Comm/Wrtg/MSL
  • Trk 07: Tech-Data- Records-Subs
  • Trk 07: Tech/Data/ Records/Subs
  • Trk 08: Reg Affairs
  • Trk 09: Med Devices-InVitro-CombProd
  • Trk 09: Med Devices/InVitro/CombProd
  • Trk 10: Pub Pol-HealthCare Compl-Law
  • Trk 10: Pub Pol/HealthCare Compl/Law
  • Trk 11: Quality in CT-GCP
  • Trk 11: Quality in CT/GCP
  • Trk 12: Pharm Quality
  • Trk 13: CER-Glob Health Econ
  • Trk 13: CER/Glob Health Econ
  • Trk 14: Clin Safety-PV
  • Trk 14: Clin Safety/PV
  • Trk 15: Statistics
  • Trk 16: Prof Development
  • Trk 17: Rare-Orphan Diseases
  • Trk 17: Rare/Orphan Diseases
  • Trk 18: Global Regulatory
  • Trk 19: DIAmond
  • Trk 20: Innov Theater
  • Trk 21: Poster Presentations
  • Trk 22: Engage and Exchange
  • Trk 23: Opening Plenary
  • Credit Type
  • ACPE
  • CME
  • IACET
  • PMI
  • RN
  • Audience
  • Advanced
  • Basic
  • Intermediate
  • Featured Topics
  • 21st Century Cures
  • Agency Participation
  • Approval Pathways
  • Audits and Inspections
  • Benefit-Risk
  • Big Data
  • Biologics-Biosimilars
  • Clinical Trial Designs
  • Clinical Trial Transparency-Clinical Trial Disclos
  • Cloud Computing
  • Community-led-Scientific Working Group Offerings
  • Current Issues in Policy and Law
  • Design Thinking
  • Disease Specific
  • Disruptive Technologies
  • Electronic Health Records (EHR)
  • Emerging Markets
  • GDUFA-Generics
  • Hot Topics in Policy and Law
  • IDMP
  • Increasing Research and Development Innovation
  • Interactive Workshop
  • Labeling
  • Mobile-Wearable Technology
  • Observational Studies
  • Partnership Strategies
  • Patient Engagement
  • Patient Recruitment and Retention
  • Patient Registries
  • Pediatrics
  • Precision-Personalized Medicine-Targeted Therapy
  • Pricing- Reimbursement and Access
  • Program Offerings for Student Attendees
  • R&D Innovation
  • Regulatory Harmonization-Convergence
  • Risk Evaluation and Mitigation Strategies (REMS)
  • Risk-Based Monitoring
  • Social Media Strategies
  • Topics Related to Asia-Pacific Region
  • Topics Related to Canada
  • Topics Related to China
  • Topics Related to Europe-EMEA
  • Topics Related to India
  • Topics Related to Japan
  • Vaccines
  • Value-Based Evidence
  • Women's Health
  • Interest Area
  • Academic Health Centers-Investigative Sites
  • Advertising & Promotion
  • Biotechnology
  • Clinical Data Management
  • Clinical Data Management - eClinical
  • Clinical Research
  • Clinical Safety & Pharmacovigilance
  • Clinical Supplies
  • CMC
  • CMC-GMP
  • Combination Products
  • Comparative Effectiveness
  • Document & Records Management
  • eClinical
  • Finance
  • Good Clinical Practices & QA
  • Information Technology
  • Manufacturing
  • Marketing & Sales
  • Medical Communications
  • Medical Devices & Diagnostics
  • Medical Science Liaison
  • Medical Writing
  • Non-clinical Safety
  • Outsourcing
  • Patient Engagement
  • Pharmaceutics
  • Pricing - Reimbursement
  • Professional Education - Training & Development
  • Project Management
  • Public Policy - Health Care Compliance - Law
  • Public Policy - Law
  • QA-QC
  • Quality Assurance - Quality Control
  • R&D - Strategic Issues
  • Rare - Orphan Diseases
  • Regulatory Affairs
  • Statistics
  • Strategic Planning
  • Study Endpoints
  • Submissions
  • Val - Electronic Info Integrity